Ke Wu Selected Research

Ke Wu Research Topics

Disease

75	Neoplasms (Cancer) 06/2022 - 05/2009
20	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2010
12	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2012
11	Neoplasm Metastasis (Metastasis) 05/2020 - 11/2010
8	Stomach Neoplasms (Stomach Cancer) 01/2020 - 10/2010
8	Insulin Resistance 12/2016 - 08/2004
7	Carcinogenesis 09/2021 - 09/2017
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2013
6	Inflammation (Inflammations) 10/2022 - 04/2011
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 05/2009
5	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 03/2019
4	Hemorrhage 03/2021 - 09/2014
4	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2018
4	Infections 01/2020 - 01/2015
4	Breast Neoplasms (Breast Cancer) 10/2019 - 04/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2009
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2019
3	COVID-19 04/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 01/2020
3	Melanoma (Melanoma, Malignant) 11/2020 - 05/2009
3	Type 2 Diabetes Mellitus (MODY) 09/2020 - 08/2004
3	Hypersensitivity (Allergy) 01/2020 - 01/2020
3	Osteosarcoma (Osteogenic Sarcoma) 09/2019 - 08/2014
3	Obesity 01/2015 - 05/2009
3	Hepatitis B 03/2013 - 07/2012
3	Body Weight (Weight, Body) 10/2010 - 03/2005
3	Hyperglycemia 08/2010 - 12/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 11/2021
2	Adenocarcinoma of Lung 01/2022 - 05/2020
2	Hypertrophy 01/2022 - 03/2021
2	Glucose Intolerance 01/2022 - 03/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 10/2016
2	Pathologic Constriction (Stenosis) 04/2021 - 04/2020
2	Silicosis 01/2021 - 11/2019
2	Fibrosis (Cirrhosis) 01/2021 - 11/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 11/2019
2	Plasmacytoma 01/2021 - 01/2020
2	Triple Negative Breast Neoplasms 12/2020 - 07/2018
2	Stroke (Strokes) 11/2020 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 12/2018
2	Intestinal Obstruction (Obstruction, Intestinal) 01/2020 - 07/2019
2	Lymphatic Metastasis 09/2019 - 11/2010
2	Carcinoma (Carcinomatosis) 02/2019 - 05/2009

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2004
14	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2004
13	MicroRNAs (MicroRNA)IBA 12/2020 - 10/2015
11	Long Noncoding RNAIBA 12/2020 - 10/2016
10	Biological ProductsIBA 10/2022 - 06/2010
10	Pharmaceutical PreparationsIBA 01/2022 - 08/2010
10	CytokinesIBA 01/2021 - 05/2009
8	Messenger RNA (mRNA)IBA 01/2022 - 10/2010
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2013
6	Insulin (Novolin)FDA Link 08/2010 - 08/2004
5	CateninsIBA 01/2020 - 07/2012
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2005
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2016
4	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2018
4	Estrogens (Estrogen)FDA Link 01/2021 - 01/2018
4	oridoninIBA 11/2018 - 08/2014
4	EnzymesIBA 11/2017 - 08/2010
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 08/2004
3	LipidsIBA 07/2021 - 01/2017
3	tetrandrineIBA 05/2021 - 03/2015
3	VaccinesIBA 04/2021 - 03/2013
3	Circular RNAIBA 01/2019 - 09/2017
3	p38 Mitogen-Activated Protein KinasesIBA 11/2018 - 02/2016
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 10/2015
3	ResveratrolIBA 07/2017 - 07/2014
3	Dimenhydrinate (DMH)FDA LinkGeneric 03/2015 - 10/2010
3	DimethylhydrazinesIBA 03/2015 - 10/2010
3	Dextrans (Dextran)FDA Link 03/2015 - 10/2010
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2015 - 10/2010
3	Carrier Proteins (Binding Protein)IBA 07/2012 - 10/2010
3	Polysaccharides (Glycans)IBA 01/2010 - 03/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 04/2017
2	Neuroprotective AgentsIBA 01/2022 - 01/2019
2	LigandsIBA 01/2022 - 01/2018
2	Coenzyme A (CoA)IBA 04/2021 - 06/2013
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2018
2	CollagenIBA 01/2021 - 11/2019
2	astragaloside AIBA 01/2021 - 11/2019
2	InterleukinsIBA 01/2021 - 01/2019
2	Therapeutic UsesIBA 12/2020 - 01/2019
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2020 - 02/2016
2	1-ethyl-2-benzimidazolinoneIBA 01/2020 - 01/2020
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2020 - 01/2020
2	Immunologic Factors (Immunomodulators)IBA 01/2020 - 01/2020
2	ApaminIBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2017
2	Gemcitabine FDA Link 01/2019 - 06/2013

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2004
9	Drug Therapy (Chemotherapy) 06/2022 - 07/2012
4	Immunotherapy 01/2021 - 10/2015
3	Stents 11/2019 - 03/2019
2	Transplantation 12/2021 - 01/2019
2	Operative Time 07/2019 - 06/2018